Enfusion, INC

Enfusion, Inc. has completed its merger with Clearwater Analytics Holdings, Inc., resulting in Enfusion becoming a wholly-owned subsidiary of Clearwater.

Enfusion, Inc. stockholders voted to approve the merger agreement with Clearwater Analytics at a special meeting held on April 17, 2025.

Clearwater Analytics and Enfusion have announced the preliminary results of the election by Enfusion shareholders regarding the form of merger consideration they wish to receive in connection with Clearwater's acquisition of Enfusion.

Enfusion amends its definitive proxy statement/prospectus related to its acquisition by Clearwater Analytics, addressing stockholder lawsuits and providing supplemental financial projections.

Enfusion and Clearwater Analytics announce the deadline for Enfusion shareholders to elect the form of merger consideration they wish to receive in connection with Clearwater's acquisition of Enfusion is April 16, 2025.

Enfusion reports a 13.9% increase in Q4 revenue and announces its acquisition by Clearwater Analytics, expected to close in the second quarter of 2025.

Enfusion Inc. reported a 15.4% increase in total revenue for the third quarter of 2024, driven by growth in platform subscriptions, while also increasing investments in technology and development.

Enfusion Inc. announced a 15.8% increase in total revenue for the second quarter of 2024, reaching $49.5 million, driven by growth in platform subscriptions and managed services.

Enfusion, Inc. announced its first quarter 2024 results, showing revenue growth driven by platform subscriptions and managed services, but also an increase in operating expenses leading to a net loss.

Enfusion, Inc. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted disclosures related to directors, executive compensation, and related matters, ahead of its expected acquisition by Clearwater Analytics.

Enfusion, Inc. will be acquired by Clearwater Analytics in a merger valued at approximately $1.5 billion, combining cash and stock.

Enfusion Inc.'s 2023 annual report showcases a year of revenue growth, strategic expansion, and continued investment in its cloud-based investment management platform.

ICONIQ Strategic Partners V, L.P. and related entities report the disposition of Enfusion, Inc. shares and common units following the merger with Clearwater Analytics Holdings, Inc.

Director Roy Luo reports the disposal of Enfusion shares and common units following the merger agreement with Clearwater Analytics, where eligible shares were converted into the right to receive cash or Clearwater Analytics stock.

Neal Pawar, Chief Operating Officer of Enfusion, Inc., reports the disposal of shares following the company's merger with Clearwater Analytics Holdings, Inc.

Bradley Herring, CFO of Enfusion, Inc., reports the disposal of all Enfusion securities following the completion of a merger with Clearwater Analytics Holdings, Inc.

Oleg Movchan, CEO of Enfusion, Inc., reports the disposal of shares following the merger with Clearwater Analytics Holdings, Inc.

Lawrence Leibowitz, a director at Enfusion, Inc., reports the disposal of all Enfusion shares following the completion of a merger with Clearwater Analytics Holdings, Inc.

Enfusion, Inc. and Clearwater Analytics Holdings, Inc. announce a supplement to their merger agreement, modifying the joint election procedure for Enfusion stockholders.

Clearwater Analytics is set to acquire Enfusion, a provider of SaaS solutions for investment management, in a transaction valued at approximately $1.5 billion.

Enfusion and Clearwater Analytics announced the expiration of the Hart-Scott-Rodino Act waiting period, moving their proposed acquisition closer to completion, expected in the second quarter of 2025.

Enfusion and Clearwater Analytics are set to merge, creating a comprehensive front-to-back technology platform for the investment industry, with the deal expected to close in the second quarter of 2025.

Enfusion has entered into a definitive agreement to be acquired by Clearwater Analytics, with the transaction expected to close in Q2 2025, aiming to create a comprehensive front-to-back platform for investment management.

Enfusion, Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on June 13, 2024, with key proposals including the election of directors and ratification of the company's accounting firm.